Brent Zettl, President and CEO

Prior to becoming the President and CEO of ZYUS, Mr. Zettl was the co-founder of Prairie Plant Systems Inc. in 1988 (“PPS”), CanniMed Ltd. in 2013 and their parent company, CanniMed Therapeutics Inc., in 2016. PPS and CanniMed Ltd. became the first two licensed producers of cannabis under the Marihuana for Medical Purposes Regulations and were the exclusive suppliers of medical cannabis to Health Canada from 2000 to 2014. In March 2018, CanniMed Therapeutics Inc. was acquired by Aurora Cannabis Inc. for approximately CAD$1.2 billion, the largest acquisition of a cannabis company at the time.

Keith Carpenter, Chief Strategy and Investment Officer

Mr. Carpenter, BA (Economics), MBA, CFA, has more than 20 years of investment experience, spanning both the buy and sell-side. He has spent the last ten in agriculture equity research, where he was a Brendan Wood Top Gun-ranked analyst and StarMine Award recipient.

Dr. Lionel Marks de Chabris, Chief Medical Officer

As a leading expert in chronic pain management and addictions medicine, Dr. Marks de Chabris brings 30 years of medical expertise to ZYUS where he is Chief Medical Officer, chairman of ZYUS’ Clinical Advisory Committee and spearheads the company’s Healthcare Practitioner Education Program. Prior to joining ZYUS, Dr. Marks de Chabris established one of only three Chronic Pain Management centers in northern Ontario. He continues to serve as an assistant professor at the Northern Ontario School of Medicine. Dr. Marks de Chabris’ pain management practice is recognized by the Ontario Medical Association and he has been accepted by the Ontario Superior Court as an expert in pain medicine and addiction medicine. In addition, he is a diplomate of the Canadian Academy of Pain Management and the American Board of Addiction Medicine, and he is acknowledged as a Fellow of the College of Family Physicians of Canada with expertise in addiction medicine.

John Hyshka, Chief Financial Officer

Mr. Hyshka, B. Comm. (Finance), has more than 20 years of experience as a business and finance leader in the life sciences space. He has extensive experience establishing and scaling high-growth companies and a proven track record in raising capital. Throughout his career, he has successfully raised over $75 million in Canada for different small to mid-size enterprises in the agriculture, medical device, and therapeutics industries.